Vincent Lo Re

8.2k total citations · 3 hit papers
163 papers, 4.6k citations indexed

About

Vincent Lo Re is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Vincent Lo Re has authored 163 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Hepatology, 87 papers in Epidemiology and 40 papers in Infectious Diseases. Recurrent topics in Vincent Lo Re's work include Hepatitis C virus research (90 papers), Liver Disease Diagnosis and Treatment (63 papers) and Hepatitis B Virus Studies (38 papers). Vincent Lo Re is often cited by papers focused on Hepatitis C virus research (90 papers), Liver Disease Diagnosis and Treatment (63 papers) and Hepatitis B Virus Studies (38 papers). Vincent Lo Re collaborates with scholars based in United States, United Kingdom and Qatar. Vincent Lo Re's co-authors include Jay R. Kostman, Amy C. Justice, Craig A. Umscheid, Baligh R. Yehia, Asher J Schranz, Adeel A. Butt, Stephen J. Gluckman, Janet P. Tate, Valerianna Amorosa and David S. Goldberg and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Vincent Lo Re

158 papers receiving 4.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Treatment Cascade for Chronic Hepatitis C Virus Infection in the United States: A Systematic Review and Meta-Analysis

2014 340 citations Vincent Lo Re et al. profile →
Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases– Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

2023 115 citations Debika Bhattacharya, Vincent Lo Re et al. profile →
Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake

2025 17 citations Vincent Lo Re, David A. Fiellin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vincent Lo Re United States	35	2.5k	2.3k	1.1k	536	280	163	4.6k
Gail Matthews Australia	41	3.8k 1.5×	3.7k 1.6×	2.2k 2.1×	252 0.5×	224 0.8×	219	5.8k
Harrison Alter United States	42	5.2k 2.1×	5.5k 2.4×	809 0.7×	517 1.0×	222 0.8×	119	7.9k
Marina B. Klein Canada	47	3.6k 1.5×	2.7k 1.2×	2.7k 2.5×	916 1.7×	238 0.8×	288	6.6k
Andrew H. Talal United States	35	2.6k 1.1×	2.9k 1.2×	1.2k 1.1×	183 0.3×	166 0.6×	141	5.1k
Sheldon T. Brown United States	34	2.1k 0.8×	509 0.2×	1.7k 1.6×	1.1k 2.1×	446 1.6×	113	4.0k
Kenneth E. Sherman United States	44	5.8k 2.3×	6.7k 2.9×	2.2k 2.0×	459 0.9×	375 1.3×	250	8.7k
Massimo Puoti Italy	47	6.6k 2.7×	7.0k 3.0×	2.5k 2.3×	571 1.1×	255 0.9×	263	9.1k
Sandro Vento Italy	31	1.9k 0.8×	1.6k 0.7×	738 0.7×	87 0.2×	406 1.4×	127	3.6k
Douglas T. Dieterich United States	49	7.0k 2.8×	6.9k 3.0×	2.3k 2.1×	590 1.1×	359 1.3×	258	9.3k
Pablo Barreiro Spain	46	3.8k 1.5×	3.7k 1.6×	3.6k 3.3×	964 1.8×	194 0.7×	331	7.3k

Countries citing papers authored by Vincent Lo Re

Since Specialization

Citations

This map shows the geographic impact of Vincent Lo Re's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Lo Re with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Lo Re more than expected).

Fields of papers citing papers by Vincent Lo Re

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Lo Re. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Lo Re. The network helps show where Vincent Lo Re may publish in the future.

Co-authorship network of co-authors of Vincent Lo Re

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Lo Re. A scholar is included among the top collaborators of Vincent Lo Re based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Lo Re. Vincent Lo Re is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smookler, David, Rebecca Russell, Dena M. Carbonari, et al.. (2025). Early Read‐Time Performance of the OraQuick HCV Rapid Antibody Assay for the Exclusion of HCV Viremia. Journal of Viral Hepatitis. 32(10). e70066–e70066.

Weinstein, Erica J, Dena M. Carbonari, Craig Newcomb, et al.. (2025). Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines. Open Forum Infectious Diseases. 12(5). ofaf102–ofaf102.

Re, Vincent Lo, Dena M. Carbonari, Craig Newcomb, et al.. (2025). Changes in Bone Microarchitecture and Inflammatory Cytokines After Cure of Chronic Hepatitis C Infection With Direct-Acting Antiviral Therapy. Open Forum Infectious Diseases. 12(9). ofaf571–ofaf571.

Gordon, Kirsha S., Janet P. Tate, Joseph K. Lim, et al.. (2024). Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis. JAMA Network Open. 7(11). e2443608–e2443608. 4 indexed citations

Skanderson, Melissa, Farah Kidwai‐Khan, Dena M. Carbonari, et al.. (2024). Identification of hepatic steatosis among persons with and without HIV using natural language processing. Hepatology Communications. 8(7). 5 indexed citations

Re, Vincent Lo, Craig Newcomb, Dena M. Carbonari, et al.. (2024). Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status. Pharmacoepidemiology and Drug Safety. 33(12). e70069–e70069. 1 indexed citations

Wang, Wei, et al.. (2023). Association between treatment of hepatitis C virus and risk of cardiovascular disease among insured patients with the virus in the United States. Pharmacoepidemiology and Drug Safety. 32(10). 1142–1151. 2 indexed citations

Weinstein, Erica J, Vincent Lo Re, Alisa J. Stephens‐Shields, et al.. (2023). 1312. Incidence and Microbiology of Prosthetic Joint Infection According to Time Following Total Knee Arthroplasty: A Retrospective Cohort Study Among US Veterans. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Akers, Scott, Yuankai Huo, James G. Terry, et al.. (2023). Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIV. Pharmacoepidemiology and Drug Safety. 32(10). 1121–1130.

10.

Girman, Cynthia J., Mary E. Ritchey, & Vincent Lo Re. (2022). Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products. Pharmacoepidemiology and Drug Safety. 31(7). 717–720. 95 indexed citations

11.

Justice, Amy C., Kirsha S. Gordon, Jonathon Romero, et al.. (2021). Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study. The Lancet Healthy Longevity. 2(10). e639–e650. 22 indexed citations

12.

Re, Vincent Lo, Dena M. Carbonari, Jerry Jacob, et al.. (2021). Validity of ICD‐10‐CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies. Pharmacoepidemiology and Drug Safety. 30(7). 899–909. 18 indexed citations

13.

Butt, Adeel A., Yan Peng, Obaid S. Shaikh, et al.. (2020). Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study. Journal of Hepatology. 73(2). 277–284. 29 indexed citations

14.

Do, Albert, Denise Esserman, Supriya Krishnan, et al.. (2020). Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals. Journal of General Internal Medicine. 35(7). 2025–2034. 22 indexed citations

15.

Rentsch, Christopher T., Farah Kidwai‐Khan, Janet P. Tate, et al.. (2020). Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study. PLoS Medicine. 17(9). e1003379–e1003379. 234 indexed citations

16.

Rentsch, Christopher T., Emily J. Cartwright, Neel R. Gandhi, et al.. (2018). Provider verification of electronic health record receipt and nonreceipt of direct-acting antivirals for the treatment of hepatitis C virus infection. Annals of Epidemiology. 28(11). 808–811. 3 indexed citations

17.

Midgard, Håvard, Amanda Weir, Norah Palmateer, et al.. (2016). HCV epidemiology in high-risk groups and the risk of reinfection. Journal of Hepatology. 65(1). S33–S45. 125 indexed citations

18.

Orange, Jordan S., Jason Roy, Yanli Wang, et al.. (2015). Validity of Primary Immunodeficiency Disease Diagnoses in United States Medicaid Data. Journal of Clinical Immunology. 35(6). 566–572. 6 indexed citations

19.

Re, Vincent Lo, Leanne B. Gasink, Jay R. Kostman, Debra G. B. Leonard, & Robert Gross. (2004). Natural History of Patients with Low-Level HIV Viremia on Antiretroviral Therapy. AIDS Patient Care and STDs. 18(8). 436–442. 6 indexed citations

20.

Re, Vincent Lo & Stephen J. Gluckman. (2003). Preventing Malaria When You Travel. American family physician. 68(3). 515. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact